Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor- positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER)

by | Jan 1, 2022 | Publicaciones - B-01 | 0 comments

Albanell, J; Martinez, MT; Ramos, M; O’Connor, M; de la Cruz-Merino, L; Santaballa, A; Martinez-Janez, N; Moreno, F; Fernandez, I; Alarcon, J; Virizuela, JA; de la Haba-Rodriguez, J; Sanchez-Rovira, P; Gonzalez-Cortijo, L; Margeli, M; Sanchez-Munoz, A; Anton, A; Casas, M; Bezares, S; Rojo, F – 2022